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Cross-talkG protein-coupled receptors (GPCRs) are the largest family of cell-surface receptors in mammals and facilitate a
range of physiological responses triggered by a variety of ligands. GPCRs were thought to function asmonomers,
however it is now accepted that GPCR homo- and hetero-oligomers also exist and inﬂuence receptor properties.
The Schizosaccharomyces pombe GPCR Mam2 is a pheromone-sensing receptor involved in mating and has pre-
viously been shown to form oligomers in vivo. The ﬁrst transmembrane domain (TMD) of Mam2 contains a
small-XXX-smallmotif, overrepresented inmembrane proteins andwell-known for promoting helix–helix inter-
actions. An ortholog of Mam2 in Saccharomyces cerevisiae, Ste2, contains an analogous small-XXX-small motif
which has been shown to contribute to receptor homo-oligomerization, localization and function. Here we
have used experimental and computational techniques to characterize the role of the small-XXX-small motif in
function and assembly of Mam2 for the ﬁrst time. We ﬁnd that disruption of the motif via mutagenesis leads
to reduction of Mam2 TMD1 homo-oligomerization and pheromone-responsive cellular signaling of the full-
length protein. It also impairs correct targeting to the plasma membrane. Mutation of the analogous motif in
Ste2 yielded similar results, suggesting a conservedmechanism for assembly. Using co-expression of the two fun-
gal receptors in conjunction with computational models, we demonstrate a functional change in G protein spec-
iﬁcity and propose that this is brought about through hetero-dimeric interactions of Mam2 with Ste2 via the
complementary small-XXX-small motifs. This highlights the potential of these motifs to affect a range of proper-
ties that can be investigated in other GPCRs.
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in the manuscript.G protein-coupled receptors (GPCRs) form a large ubiquitous family
of transmembrane receptors that share a common topology of sevenα-
helical transmembrane domains (TMDs). GPCRs are conserved in all
eukaryotes, where they act as key regulators of many cellular processes
by triggering intracellular signaling cascades in response to environ-
mental stimuli. Although alternative modes of activation exist, trans-
mission of information across the lipid bilayer is commonly achieved
by binding of ligand in the GPCR binding pocket, which forces a confor-
mational change in the receptor's transmembrane domains [1,2]. This
typically leads to G-protein binding, GDP–GTP exchange on the associ-
ated G protein, and propagation of the signal. GPCRs have also been
shown to form dimeric or higher order oligomeric complexes, which
may be a prerequisite for the correct subcellular targeting and func-
tioning of the receptor [3,4] and may modulate receptor function [5].
Hetero-association of two (or more) GPCRs to form new receptor com-
plexes that participate in “cross-talk” has also been reported, leading to
3037A. Lock et al. / Biochimica et Biophysica Acta 1838 (2014) 3036–3051modiﬁed G protein coupling and signaling [6]. Despite these and other
excellent studies highlighting the importance of GPCR homo- and
hetero-oligomerization, the speciﬁc interactions mediating complex
formation are poorly understood due to the signiﬁcant technical chal-
lenges involved in structural characterization of membrane proteins.
Lower eukaryotes are attractive model organisms in which to study
GPCRs as they are amenable to genetic manipulation and exhibit less
cross-talk between signaling pathways [7]. Several studies of the GPCR
Ste2, the pheromone receptor from the budding yeast Saccharomyces
cerevisiaewhichmediates the mating response, agree that oligomeriza-
tion of this protein is facilitated (at least in part) by interactions involv-
ing transmembrane domain 1 (TMD 1) [8–11]. These interactions were
further traced to a small-XXX-small motif (speciﬁcally a G56-XXX-G60
motif) in TMD 1 [12]. Small-XXX-small motifs aremotifs of two residues
(typically glycine, but also alanine or serine) separated by three amino
acids in the polypeptide chain, thus physically placing them on the
same face of an α-helix. Co-location of these two small residues results
in a “groove” which allows two helices to interlock via many favorable
van der Waals contacts, thereby promoting helix–helix interactions.
While these motifs have been frequently found at the oligomeric inter-
face of helical membrane proteins [13–16], they have also been shown
to be highly dependent upon the surrounding amino acid sequence
[17,18], and are not always effective in driving protein interactions.
Therefore, simple identiﬁcation of thesemotifs in the primary sequence
of a transmembrane domain is not a silver bullet to understanding pro-
tein interactions, but their presence can be used to design targeted mu-
tagenesis strategies to verify their role (or lack thereof) experimentally.
In this way, mutation of the G-XXX-Gmotif in Ste2 TMD1was shown in
one study to interfere with oligomerization and localization (but not li-
gand binding) of the receptor [12]. However, other studies before and
since have reported that Ste2 TMD 1 is not sufﬁcient to drive oligomer-
ization on its own, and that other domains in the receptor are also in-
volved in complex formation including the N-terminus and TMD 2,
TMD 4, and TMD 7 [9–11]. Evidence also exists that suggests the sites
of contact between receptors change upon ligand-binding [9]. More-
over, it should be noted that, while small residues may mediate TMD
packing, this is not always essential and indeed some GPCRs have
been known to include more bulky residues such as isoleucine and leu-
cine. In short, this growing body ofwork has not yet yielded a consensus
model for Ste2 oligomerization, apart from the agreement that TMD 1
participates in some way.
The Schizosaccharomyces pombe P-factor receptor Mam2 [19] is
orthologous to the Ste2 receptor, and immunoblotting (performed
under non-denaturing conditions) has suggested the existence of oligo-
meric complexes [20] although a direct interaction has not been deter-
mined. Unfortunately, classical approaches to conﬁrm dimerization of
Mam2 have proven unsuccessful. In the past we have been able to im-
munoprecipitate heterologously expressed mammalian receptors from
S. pombe cells [20,21], but somewhat surprisingly this has not been pos-
sible for Mam2 despite the production of two in-house antibodies. Like-
wise, we have been unable to utilize ﬂuorescent-based techniques such
as Förster resonance energy transfer (FRET) and bioluminescence reso-
nance energy transfer (BRET) due to the large size of the C-terminal tail
of Mam2 (45 amino acids). Unlike Ste2, where it has been possible to
delete the C-terminal tail and still produce a functional receptor [12],
Mam2 has an absolute requirement of its C-terminal tail to facilitate ef-
ﬁcient downstream signal transduction [22]. The tail of Mam2 is abso-
lutely required for an interaction with the regulator of G protein
signaling 1 (Rgs1) protein that both negatively and positively modu-
lates signal transduction dependent upon the dose of stimulating pher-
omone [22,23]. Deletion of the Mam2 C-terminal tail generates a
receptor with severely attenuated signaling abilities. Consequently, a
novel approach that attempts to understand theMam2 dimerisation in-
terface has been required andwe described here our use of the bacterial
expression system TOXCAT [24] to investigate the Mam2 dimerization
interface.Along with the suggestion that Mam2 forms oligomers [20], Mam2
further resembles Ste2 in that it also contains two consecutive small-
XXX-small motifs (G49-XXX-S53, S53-XXX-A57) in TMD 1. Given the lack
of a consensus as to the precise mechanisms governing oligomerization
of fungal GPCRs, and guided by previous studies of Ste2 as well as the
presence of well-known helix interaction motifs, we describe here for
the ﬁrst time the effects of targeted mutation of the small-XXX-small
motifs on oligomerization, function, and localization of Mam2. Equiva-
lent experiments were performed on Ste2 for comparison to Mam2
and the wider literature. Our results demonstrate that the TMD 1
small-XXX-small motifs play a critical part in the correct localization
and function of full-length Mam2, and this behavior is mirrored in par-
allel experiments performed on Ste2. The small-XXX-small motifs also
promote strong self-association of Mam2 TMD 1 in isolation (a result
which is not observed in parallel experiments on Ste2 TMD 1). Using a
series of chimeric G protein expressing strains [21], we also demon-
strate that Mam2 can form functional heterodimers with Ste2, and our
mutagenesis data suggest that this occurs via complementary small-
XXX-small motifs in the ﬁrst TMD of each receptor. Molecular models
of the relevant helix–helix interactions are used to support the experi-
mental results and illustrate plausible interaction modes. The data
presented here highlight the importance of this well-known motif and
offer novel insight into the mechanisms used by Mam2 to functionally
assemble into homo- and hetero-oligomeric complexes.
1. Materials and methods
1.1. TOXCAT assay and construction of chimera
The self-association of the ﬁrst transmembrane domains of
S. cerevisiae Ste2 (V49–W70) and S. pombeMam2 (L46–C67) were studied
using the TOXCAT assay, which has been described previously [24].
Brieﬂy, the DNA sequence encoding the transmembrane domain of in-
terest was cloned into the pccKAN vector between the dimerization-
dependentDNAbinding domain of ToxR at theN-terminus, andmaltose
binding protein (MBP) at the C-terminus. The resulting fusion protein
was expressed in Escherichia coli NT326 cells lacking endogenous MBP.
TM domain-driven oligomerization of the fusion protein leads to ToxR
mediated activation of the reporter gene chloramphenicol acetyltrans-
ferase (CAT), with CAT expression levels indicating the strength of TM
self-association. Before performing assays, correct insertion and orien-
tation of the TOXCAT constructs in the E. coli inner membrane was
conﬁrmed using the protease sensitivity in spheroplast assay [24]. Ex-
pression levels for all constructs were determined via western blots
against maltose binding protein (MBP). The chloramphenicol acetyl-
transferase (CAT) reporter gene was quantiﬁed using the FAST CAT kit
(Invitrogen). CAT activity was normalized to the expression level of
each construct using the ImageJ tool [25] to quantify band intensities
on a western blot, and all CAT activities are reported relative to the
value obtained for the positive control, the strongly-dimerizing TMD
of Glycophorin A (GpA). A point mutant of GpA, G83I, which impairs
TMD association, was used as a negative control. Values given are the
means (±S.D.) for three or more independent measurements and a
student's T-testwas performed to determine the signiﬁcance of changes
in CAT activity.
1.2. Yeast strains, plasmid construction and culture conditions
The yeast strains used in this study are listed in Table S1. All yeast
strains were derived from JY546 which contains the sxa2 N lacZ con-
struct for quantiﬁcation of pheromone-dependent transcription. To fa-
cilitate the expression of heterologous GPCRs in S. pombe, we have
previously described the generation of a series of Gα-transplants, inte-
grated at the gpa1 locus, in which the C-terminal ﬁve amino acids of
Gpa1 were replaced with the corresponding residues frommammalian
Gα-subunits [21]. General yeast procedures are as described previously
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media used was DMM (a deﬁned minimal media for selective growth
and all assays). The pREP vectors allow expression of genes under the
control of the thiamine-repressible, nmt1 promoter; pREP3x contains
the nutritional selection marker LEU2 and pREP4x, and ura4 [28].
S. pombe genes were ampliﬁed from genomic DNA via PCR using
FastStart high ﬁdelity polymerase blend (Roche Diagnostics Ltd., UK)
and cloned into the pREP vectors. All Ste2 and Mam2 mutations were
generated by inverse PCR and constructs sequenced to ensure faithful
ampliﬁcation. Fluorescent and Gpa1 fusion constructs were generated
using a two-step cloning technique as described previously [21]. The
Ste2 open reading frame was ampliﬁed using JO1372 (ATGTCTGATG
CGGCTCCTTC; upper case letters are complementary to positions 1 to
20) and JO1373 (TAAATTATTATTATCTTCAG; upper case letters
are complementary to positions 1293 to 1274) removing the stop
anti-codon from the ORF, and were cloned into unique EcoRV
sites of JD1698 (a modiﬁed version of the pREP vector containing
the GFP ORF with an EcoRV site immediately upstream of the initi-
ator codon of GFP), JD1773 (pREP containing Gpa1) and JD2735
(pREP the inactive mutant of Gpa1 [G242A]) [20]. We have previ-
ously described the generation of Mam2-Gpa1 and Mam2-Gpa1
[G242A] constructs [20].
1.3. Assay of β-galactosidase activity
Assays were performed as described previously [21,29]. Cell concen-
trations were determined using a Coulter Channelyser (Beckman
Coulter).
1.4. Computational searches using CHI
Structural calculations were performed using the CNS searching of
helix interactions (CHI) software package, which has been previously
described [30,31], on an 8-node dual 2.66-GHz Xenon processor Linux
cluster (Streamline Computing, Warwick). CHI was used to create
homodimer models from two parallelα-helices containing the predict-
ed sequences of either Mam2 or Ste2 TMD 1 (L46–L61 and V49–I67 for
Mam2 and Ste2, respectively), using previously published parameters
for the search (e.g. starting crossing angle and interhelical distance,
and rotation step size) [14]. Heterodimer models were created from
parallel α-helices containing residues V49–W70 of Ste2 and L46–C67 of
Mam2 using the same starting parameters described above. Groups of
a minimum of 10 structures with a backbone RMSD of ≤1 Å were clus-
tered and the average structure for each cluster was calculated. In the
case of homo-dimers, only clusters containing symmetrical dimers
were considered. Each search was carried out three to ﬁve times to
check for frequency of a given model.
1.5. Model GPCR dimeric structures
A number of GPCR crystal structures contain dimers within the
asymmetric unit, and while some are clearly not biologically meaning-
ful, others present TMD 1 as part of the dimeric interface. The PISA
software [32], www.ebi.ac.uk, is useful for addressingwhether a crystal-
lographic dimer is the correct biological dimer and can also identify
other dimeric interfaces within the crystal lattice. In order to analyze
whether any of these GPCR dimeric structures [33] are relevant, we
have aligned TMD 1 of 112 Ste2/Mam2 homologues to class A/class B/
class C/class E GPCR homologues. The position of TMD 1 for the Mam2
receptor was predicted using the topology prediction tool TMHMM
[34]. These alignments are within or below the twilight zone, and so
are potentially difﬁcult, but elsewherewe have presented a novel align-
ment method that correctly aligned the known TMDs for class A and B
GPCRs [35]. The method is essentially based on a helix by helix proﬁle
alignment, with the following additional features. Firstly, all pairwise
alignments are considered and each possible alignment receives avote if it is the top scoring pairwise alignment. Secondly, entropy is in-
cluded via a maximum lagged correlation [36]. Elsewhere we also in-
cluded amino acid volume [35] and hydrophobicity [35,36], but here
we restrict ourselves to the more reliable pairwise alignments and en-
tropy. The approaches are combined by scaling the votes (or the
correlation coefﬁcients) between 0 and 1 and multiplying together,
so that alignments that receive minimum support are eliminated
and alignments that receive strong support are promoted. Here
we additionally included the product of pair wise alignments over
multiple classes, and similarly for entropy. The alignment enabled
us to map the G-XXX-G motifs onto the opsin dimer (PDB code
3CAP) [37].
1.6. Confocal microscopy
Measurements were performed as described previously [22,38].
Strains cultured in DMMwere harvested washed twice in fresh growth
mediumand transferred to poly-lysine-coated slides (Sigma-Aldrich Co.
Ltd.). Cellswere viewed using a Personal DeltaVision (Applied Precision,
Issaquah, WA) comprising, an Olympus UPlanSApo 100×, N.A. 1.4, oil
immersion objective and a Photometric CoolSNAP HQ camera (Roper
Scientiﬁc). Captured images were processed by iterative constrained
deconvolution using SoftWoRx (Applied Precession) and analyzed
using ImageJ. All images were captured in a z-stack with the highest in-
tensity chosen.
1.7. Image analysis
Image analysis was performed using the open source program
ImageJ (http://rsb.info.nih.gov/ij/). Cell segmentation was achieved
using the BOA plug-in component of the Quantitative Imaging of
Membrane Proteins (Quimp) package (http://go.warwick.ac.uk/
bretschneider/quimp) [39–41]. 30 yeast cells were selected at random
for analysis as previously described [39] and representative images
were shown. For many of the GPCRs analyzed in this study, cell surface
expression was signiﬁcantly impaired. This reduction in cell surface ex-
pression correlated with a reduction in the magnitude of the signaling.
To provide a quantitative comparison of all receptors measured, we
corrected the extent of signaling by accounting for the percentage of
cell surface expression. The wildtype receptors were used as our refer-
ence. We have used similar techniques previously to correct signaling
responses where ligands have had toxic affects [38].
1.8. Immunoblotting of GPCRs
Plasma membrane extracts were prepared from yeast strains con-
taining various pREP vectors expressing the different Mam2 and Ste2
constructs grown in minimal medium lacking thiamine to ~1 × 10 [7]
cells ml−1 using the method described [20]. Samples were resolved
using non-denaturing SDS-PAGE and transferred to polyvinyl diﬂuoride
(PVDF) membrane with a semidry blotter. Western blotting was per-
formedusing a rabbit GFPmonoclonal antibody (Santa Cruz Biotechnol-
ogy Inc, Santa Cruz, California, USA) or a rabbit polyclonal anti-6-His
(Abcam, Cambridge, UK) as the primary antibody as appropriate. A don-
key anti-rabbit IgG horse-radish peroxidase (HRP) conjugate
(Amersham, International, Little Chalfont, Buckinghamshire, UK) was
used as the secondary antibody. Antibodies were used according to
the manufacturers' instructions. HRP activity was detected using ECL
substrate (Amersham).
1.9. Data analysis
Data were analyzed using GraphPad Prism v6.0c for Mac OS X
(GraphPad Software Inc, San Diego, CA). Concentration response curves
were ﬁtted using the three-parameter logistic equation to obtain pEC50
for agonists. The operational model for partial agonism [42] was used to
Fig. 1.Mam2 TMD 1, but not Ste2 TMD 1, self-associates strongly in a biological membrane via the S53-XXX-A57 motif. (A) Alignment of the primary sequences of putative transmembrane do-
main 1 (TMD 1) in the S. pombeMam2 and S. cerevisiae Ste2 receptor. The small-XXX-small motifs are boxed. (B) Sequences of theMam2 and Ste2 TMD 1 TOXCAT inserts that were studied in
this report. The TOXCAT system (as detailed in Materials and methods) is sensitive to the length and sequence of the TMD insert, so multiple sequence inserts were tested. (C) CAT activities
obtained in the TOXCAT assay for the wild-type and mutant Mam2 TMD 1 constructs. (D) CAT activities obtained in the TOXCAT assay for the wild-type Ste2 TMD 1 constructs. CAT activities
were normalized to expression level of each construct and the CAT activity of the positive control, GpA. Results aremeans± S.E.M. for triplicatemeasurements from three independent isolates.
3039A. Lock et al. / Biochimica et Biophysica Acta 1838 (2014) 3036–3051obtain relative values of efﬁcacy (log τ) and the equilibriumdissociation
constant (log KA). Results are expressed as means ± S.E.M. unless
otherwise stated. Statistical analyses were performed by using a
one-way ANOVA with a Tukey's multiple comparison post-test, or
one-way analysis of variance followed by Bonferroni's post-test,
as appropriate. Values of p b 0.05 were considered statistically
signiﬁcant.2. Results
2.1. Conservation of small-XXX-small motifs in TMD 1 of Mam2 and Ste2
and other class A/B/C/E GPCR sequences
Inspection of the primary sequence of TMD 1 from theMam2 recep-
tor, predicted using the topology prediction tool TMHMM [34] revealed
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3041A. Lock et al. / Biochimica et Biophysica Acta 1838 (2014) 3036–3051that it contains two consecutive small-XXX-small motifs; G49-XXX-S53
and S53-XXX-A57 (boxed, Fig. 1A). The same is true for the Ste2 receptor
TMD 1, containing both A52-XXX-G56 and G56-XXX-G60motifs (although
only the G56-XXX-G60 motif has been highlighted in the literature).
Sequence alignment of the full-length Mam2 and Ste2 proteins using
Clustal [43,44] revealed that the Ste2 G56-XXX-G60 motif in TMD 1,
shown previously to affect oligomer formation and function of the re-
ceptor [12], aligns to the more C-terminal small-XXX-small motif in
Mam2 TMD 1 (S53-XXX-A57, see Fig. 1A). The alignment was produced
using the full-length proteins, but only the sequences of the ﬁrst TMD
are shown for clarity. The alignment of the full-length proteins revealed
a low sequence identity between the two (see Fig. S1 for full-length
alignment), reﬂecting their long evolutionary distance.
We have previously described a new approach to enable the align-
ment of GPCR family TMs [35,36]. We observed that GCR1, the only
well-characterized plant GPCR, had sequence similarity to both class A
and class B GPCRs and that class E homologues have been proposed as
the ancestral sequences for class A and class B GPCRs. Using this evi-
dencewewere able to align class A GPCRswith class B. Thus, to provide
a comprehensive analysis of the conservation of the small-XXX-small
motif in other Class D GPCRs as well as other families of GPCRs, we
aligned Mam2/Ste2 homologues (class D) to class A, class B, class C
and class E GPCRs (the class A/B/C/E alignment is well deﬁned [35,45]
so an alignment to class A deﬁnes the alignment to class B etc.).We gen-
erated consensus scores from two different analyses (helical alignment
and entropy correlation coefﬁcients). Fig. 2A shows the pairwise helical
alignments evaluated, using the PHAT matrix, of 17 alternative variants
forMam2/Ste2 homologue TM1 to class A, class B, class C and class E. All
alternatives yield different preferred alignments, however, when scaled
(Fig. 2D) we see a distinct preference for alignment 0, which we report
for the predicted TM1 and ﬂanking regions of several GPCRs in Fig. 2G.
We next evaluated the alignments using entropy (Fig. 2B/E). While en-
tropy does not necessarily favor the correct alignment, it usually gives a
reasonable score for the correct alignment [35]. Fig. 2C shows the prod-
uct of the scaled votes for the pairwise alignments multiplied by the
scaled entropy scores for the alignments over all four classes and
again we see a strong preference for alignment 0 (Fig. 2F). Given that
the pairwise scores aremore reliable than the entropy scores, the results
in Fig. 2D should be given the strongest weight. Thus, the Class A/
Mam2/Ste2/Class B and Class E alignment 0 is given in Fig. 2G (from
which the alignment to Class C can be inferred [35,45]). From inspection
of the primary sequences in this alignment we can see that the small-
XXX-small motifs in Ste2 andMam2 are conserved across several mem-
bers of Class D GPCRs, but these motifs are only weakly conserved in
other classes.
2.2. Strong, sequence-dependent oligomerization of Mam2 (not Ste2) TMD 1
The propensity for TMD 1 in Mam2 (and Ste2 for comparison) to
self-associate in isolation was assessed using the TOXCAT assay. This
assay allows inducible (if required) expression of a TM domain of inter-
est as part of a fusion protein, and qualitative evaluation of the propen-
sity of that TM helix to self-associate in a natural (albeit not always
native) bacterial membrane. It offers a relatively straightforward and
robust platform upon which to screen the effects of point mutations,Fig. 2. The TMD1 sequence alignment between selectedMam2/Ste2 homologues and selected cl
1) for each of the 17 alternative pairwise alignments evaluated using the PHAT matrix, denote
Figure 2G; alignment−1 corresponds tomoving the S2 sequence 1 position to the left. The lege
ment evaluated using entropy (scaled between 0 and 1), denoted SA, SB, SC and SD respectively.
i.e. VA × SA, VB × SB, VC × SC and VD × SD. (D) The preferred alignment as indicated by the produ
product of the scaled entropy: SA × SB × SC × SD. (F) The preferred alignment as indicated by the
1.50 (the most conserved position in class A) is marked by a vertical bar and is the conserved N
receptor are marked by an ‘X’. The Mam2/Ste2 small residues of the small-XXX-small-XXX-sm
color reﬂects the biophysical properties. The residues are color coded according to their prope
matic; green, large hydrophobic; yellow, small hydrophobic. This corresponds to the Taylor schand has provided a means to investigate sequence speciﬁc interactions
formembrane proteins that are extremely difﬁcult to express and purify
in their full-length forms. One of themain drawbacks of this assay is that
it is most appropriate for the study of single transmembrane domains,
which can complicate data interpretation when studying multi-
spanning membrane proteins. An additional trait of this assay is that,
in our hands [14] and in other labs [46] this system is sensitive to the
length and amino acid sequence of the TMD inserted, therefore ﬁve dif-
ferent constructs containingMam2 TMD1 sequences of varying lengths
and sequence frames were prepared (Fig. 1B). To compare the Mam2
results in this assay to similar results for Ste2 TMD1 (which has never
been investigated using the TOXCAT assay), we prepared seven differ-
ent constructs containing Ste2 TMD 1 inserts (Fig. 1B). Alongside
these constructs, we also measured the oligomerization of the strongly
dimerizing Glycophorin A TMD (positive control) and the G83I mutant
of this domain which destabilizes the dimer (negative control) as de-
scribed previously [24].
The CAT activities for the variousMam2TMD1 constructs are shown
in Fig. 1C.Western blots againstMBP to demonstrate relative expression
levels of the full-length chimeras (CAT activities were normalized to ex-
pression level) are shown in Figure S2 (panel A, see band at ~62 kDa).
Mam2 TMD 1 was found to form intermediate-strong oligomers in the
E. coli innermembrane (Fig. 1C, see constructs 13A, 16, and 18), yielding
CAT activities of up to 75% that observed for GpA (construct 16). The po-
sition of the small-XXX-small motif in the membrane is known to inﬂu-
ence the strength of helix–helix interactions, with motifs located near
the center of the TMD capable of forming stronger interactions thanmo-
tifs located near the lipid head group region [47]. The TOXCAT assay is
also sensitive to the topology of the inserts, with insert length and the
rotational positioning of the ToxR domains relative to each other
inﬂuencing the expression of CAT [14,46,48]. We exploited the fact
that centrally located motifs produce stronger TOXCAT signals to differ-
entiate the roles of the two small-XXX-small motifs present in Mam2
TMD1. Eachmotif was centered in themiddle of a 13-amino acid insert,
producing two constructs with slightly different sequences. Centering
the S53-XXX-A57 motif (13A in Fig. 1B) leads to a higher normalized
CAT activity (42% of GpA) than centering the G49-XXX-S53 motif (13B
in Fig. 1B), which produced a normalized CAT activity 10% that of GpA
(and equivalent to the negative control, G83I).
Because the S53-XXX-A57motif appeared to be a strongermediator of
Mam2 TMD 1 dimer formation, S53 and A57 were mutated to Leu in the
TOXCAT construct that yielded the highest degree of oligomerization
(16 amino acid insert), and the CAT activity was re-measured. Leucine
substitutions at these positions reduced the normalized CAT activity
by 72% compared to wild-type TMD 1 (Fig. 1C), suggesting a substantial
reduction in the strength of oligomerization when close packing of the
S53-XXX-A57 motif was disrupted.
For Ste2, western blots against MBP (Fig. S2, panel B) revealed that
the constructs containing 19 and 20 amino acid TMD inserts were rap-
idly cleaved in vivo, leaving only MBP (see band at ~40 kDa) visible
on the gels and suggesting the absence of full-length chimera. Therefore
these two constructs were not investigated further. A signiﬁcant
amount of cleavage (N50%) was also observed for the 13 and 18
amino acid TMD constructs, and very low CAT activities were observed
for both of these. Surprisingly, even for the remaining constructsass A, selected class B sequences andGCR1. (A) The number of votes (scaled between 0 and
d VA, VB, VC and VD respectively [75]. Alignment 0 corresponds to the alignment given in
nd for panels A–C is shown in the box. (B) Themaximum correlation values for each align-
(C) The preferred alignment as indicated by the product of the number of votes × entropy,
ct of the scaled votes: VA × VB × VC × VD. (E) The preferred alignment as indicated by the
product of the votes × entropy: VA × VB × VC ×VD× SA × SB × SC × SD. (G) Generic position
, at position 22. The helical region of rhodopsin and the corticotrophin releasing hormone
all motif are marked by ‘#’. These are not conserved as small residues in other classes. The
rties as follows: blue, positive; red, negative or small polar; purple, polar; cyan, polar aro-
eme, as implemented in Jalview [76].
Fig. 3.Molecular models of the Mam2 and Ste2 TMD 1 homo- and hetero-dimers. The most frequently observed structures of the Mam2 homodimer in replicate searches contained the
S53-XXX-A57motif at the dimer interface (A), however structureswere also observed containing Q55 (B) and L52-XXX-L56 at the dimer interface (C). Similarmodels were obtained for Ste2
TMD 1 homodimers, containing either A52, G56, and G60 (D and F) or polar residues (e.g. Q51 and R58) at the dimer interface (E). Models obtained from multiple Mam2 (white) — Ste2
(black) hetero-dimer searches suggest that interactions aremediated either by the central small-XXX-smallmotif in both (G) or only one (H) helix, or a pair of polar residues (I). Allmodels
were obtained by performing searches using the program CHI (see Materials and methods).
3042 A. Lock et al. / Biochimica et Biophysica Acta 1838 (2014) 3036–3051investigated in the assay in which little to no cleavage occurred, Ste2
TMD 1 was not found to strongly oligomerize (Fig. 1D). The 25 amino
acid TMD insert showed the highest CAT activity, which was only 30%
that of GpA.
2.3. Homo-dimer models of Mam2 suggest packing of small-XXX-small
motifs
The TOXCAT data suggest that, outside the context of the full-length
GPCR, Mam2 TMD 1 strongly self-associates in a sequence dependentmanner, while Ste2 TMD 1 only weakly self-associates. To better under-
standwhat structural features stabilize the oligomeric form of the TMD,
computational models were produced using the program CHI [30,31].
The predominant Mam2 TMD 1 homo-dimer model observed across
multiple searches was a symmetric, right-handed homo-dimer contain-
ing the S53-XXX-A57motif at the dimer interface (see Fig. 3A for a repre-
sentative structure). We also observed a dimer mediated by an
interhelical hydrogen bond between the side-chain amide of Q55 to
the backbone carbonyl oxygen of L52 on the opposite helix (Fig. 3B, hy-
drogen bondswere assignedwhen ahydrogenbonddonor and acceptor
3043A. Lock et al. / Biochimica et Biophysica Acta 1838 (2014) 3036–3051were within 2.8 Å of one another). This solution was, however, not ob-
served in every search, aswas the S53-XXX-A57 dimer. The only symmet-
rical left-handed dimer observed in multiple trials contained a motif of
L52-XXX-L56 (Fig. 3C), but this solution also did not occur in every search.
Homo-dimer searches for Ste2 TMD 1were also carried out for com-
parison, despite the fact that this TMD showed very little propensity to
self-associate in TOXCAT. As with Mam2, two general types of right-
handed homodimers were observed for Ste2 TMD 1, one containing
small-XXX-small motifs at the dimer interface (in this case A52-XXX-
G56-XXX-G60, Fig. 3D) and one in which a Gln residue (Q51) forms inter-
molecular hydrogen bonds (Fig. 3E). The only symmetrical left-handed
dimer observed also contained the A52-XXX-G56-XXX-G60motif (Fig. 3F)
at the dimer interface. Interestingly, we observed that the structures of
Ste2 homo-dimers were all loosely-packed, with little to no close pack-
ing of the Gly residues.Mam2-GFP Mam2G49L-GFP
Mam2S53L-GFP Mam2A57L-GFP
Mam2G49L,S53L-GFP
A
C
PM EE
Mam2S53L,A57L-GFP
Fig. 4. Mutating the small-XXX-small motif reduces sensitivity to pheromone, maximal sign
expressed from the JY1169 Mam2-D10, sxa2 N lacZ reporter strain [21] was measured in ye
Mam2 (●), Mam2G49L (□), Mam2S53L (▲), Mam2A57L (▼), Mam2G49L,S53L (♦), and Mam2S53L,A
ﬁtted using the operational model for receptor depletion. Results are means± S.E.M. of triplica
tants was described in A and B. Plasmamembrane (PM) and early endosome structures (EE) are
imaged in C. (E) Percentagemembrane ﬂuorescence of the Ste2mutants imaged in C. Values sh
wildtype receptor (Mam2-GFP or Ste2-GFP)was determined using a one-wayANOVAwith a Tu
(F) Scaled responses for the Mam2mutants shown in A but accounting for the differences in ex
shown in B and extend of plasma membrane localization from E.2.4. Effects of mutations in the small-XXX-small motif onMam2 function in
vivo
Given the previously-demonstrated importance of the Ste2
G56-XXX-G60 motif in oligomerization, signaling and trafﬁcking [8,10,
12] and the identiﬁcation of a similar small-XXX-small motif that pro-
motes TMD 1 interactions in Mam2, it remained to be investigated
whether the S53-XXX-A57 motif could have an impact on full-length
Mam2 function in vivo. Cells expressing Mam2 were treated with
increasing concentrations of pheromone (0–100 μM), and the ability
of Mam2 to sense pheromone and relay the signal intracellularly was
quantiﬁed by means of the reporter protein β-galactosidase, as
described in the Materials and methods section. The ability of cells to
respond to pheromone when expressing Mam2 from the inducible
nmt1 promoter was comparable to expression of the gene from itsSte2-GFP Ste2G56L-GFP
Ste2G60L-GFP Ste2G56L,G60L-GFP
B
PM EE
aling and receptor localization. Pheromone dependent transcription of β-galactosidase
ast expressing GFP-tagged receptors from the inducible nmt1 promoter; (A) wild-type
57L (×). (B) Wild-type Ste2 (●), Ste2G56L (□), Ste2G60L (▲), and Ste256L,G60L (♦). Data was
te determinations from three independent isolates. (C) Subcellular localization of the mu-
highlighted. Scale bar 5 μm. (D) Percentagemembrane ﬂuorescence of theMam2mutants
own aremeans± SEM of 30 independent representative cells. Statistical signiﬁcance from
key'smultiple comparison post-test; **representing p b 0.01 and ***representing p b 0.001.
tend of plasma membrane localization from D. (G) Scaled responses for the Ste2 mutants
** **
*** *** *** ******
ED
GF
Fig. 4 (continued).
3044 A. Lock et al. / Biochimica et Biophysica Acta 1838 (2014) 3036–3051chromosomal locus [20].We found that single pointmutations of any of
the small residues in the small-XXX-small motifs of Mam2 TMD 1 (G49,
S53 or A57) to Leu resulted in the reduction of Mam2-derived cellular
signaling (Fig. 4A). It appeared as though cells were affected both in
their ability to sense pheromone, and in terms of maximal response
elicited. The most pronounced effect was observed with the S53L and
A57L mutations, although the G49L mutation also had an effect. This is
not unexpected as G49 is predicted to lie on the same helical face as
S53 and A57, although residues located close to the TM core tend to con-
tribute more strongly to helix–helix interactions [47]. We also found
that simultaneous mutation of both G49 and S53 to Leu or S53 and A57
to Leu resulted in a compounded reduction in signaling. Subsequent ap-
plication of an operational model of receptor depletion (see Materials
and methods) to the data yielded a value for P-factor afﬁnity (log
KA =−7.0 ± 0.16). The model also enabled the determination of the
relative efﬁcacy (log τ) for the wildtype and receptor mutants as
given in Table 1. The relative efﬁcacy values were found to be signiﬁ-
cantly different from wildtype (p b 0.01) for the Mam2S53L-GFP,
Mam2A57L-GFP, Mam2G49L,S53L-GFP and Mam2S53L,A57L-GFP mutants.Table 1
Relative efﬁcacy values (log τ) obtained for thewildtypeMam2 and Ste2 receptors and the
receptor mutants in which the small-XXX-small motifs were disrupted (n = 3–5).
Mam2 Construct log τ Ste2 construct Log τ
Mam2-GFP 0.89 ± 0.14 Ste2-GFP 1.58 ± 0.64
Mam2G49L-GFP 0.06 ± 0.03
Mam2S53L-GFP −0.15 ± 0.04 Ste2G56L-GFP −0.71 ± 0.33
Mam2A57L-GFP −0.11 ± 0.04 Ste2G60L-GFP −0.84 ± 0.37
Mam2G49L,S53L-GFP −0.67 ± 0.16 Ste2G56L,G60L-GFP −1.16 ± 0.49
Mam2S53L,A57L-GFP −0.59 ± 0.13Our molecular modeling also suggested that, in addition to the
small-XXX-small motif, Q55 in TMD 1 of Mam2 may also be a site of
TM helix interactions. In Ste2, the equivalent residue (R58) has been
shown to form part of the ligand-binding domain [49], and mutation
of this residue severely attenuated ligand-binding (althoughmembrane
localization was not investigated). Analogous to the Ste2 data, we have
previously identiﬁed a mutation of this residue, Mam2Q55L, during a
random mutagenic screen for inactive mutants and constitutive
mutants of Mam2 [50]. Mam2Q55L was unable to induce any signiﬁcant
response within cells (Emax: Mam2 = 22.23 ± 0.77; Mam2Q55L = 0).
To further explore the role of Q55, we used our sequence alignments
of TMD 1 given in Fig. 2G to map the small-XXX-small-XXX-small motif
onto the opsin dimer (Fig. 5). Of the current crystal structures available,
only the opsin dimer showed good alignment of the small-XXX-small
motif although only the ﬁrst residue (A41) is small in rhodopsin. These
residues (A42, L47, L50, shown as spheres colored by atom type in Fig.
5A and B) nevertheless mediate the dimeric interaction in the opsin
dimer. The opsin residue I48, analogous in position to theMam2Q55 res-
idue and shown in pink in Fig. 5A and B, is facing inwardly and strongly
interacts with TM2. This suggests that the Q55 residue in Mam2 is simi-
larly positioned and thus unable to perform any signiﬁcant role inmedi-
ating the dimer interaction. Therefore, this mutation was not explored
further.
To compare the effects of homologous mutations on Ste2 function
using our assay, and compare our results to existing literature in this
area, we ﬁrst needed to establish that Ste2 could be functionally
expressed in S. pombe. Although we have previously described the
ability to heterologously express GPCRs from mammalian cells in
S. pombe [20,21], we had not (until now) expressed the Ste2 from
S. cerevisiae. Overall Mam2 and Ste2 share very little sequence homolo-
gy (16.7%— EMBOSS Needle) [51], however this value increases to near
Fig. 5.Molecular modeling of theMam2 using the opsin dimer. Two views of the opsin dimer (PDB ID 3CAP) with the small-XXX-small-XXX-small motif mapped onto A41, L45 and L49 of
TMD1 (shown as spheres and colored by atom type) in of the rhodopsin sequence in accordancewith the alignment in Fig. 2G. TMD1 is themajor component of the interface. Ile48 (shown
as spheres and colored pink), which corresponds to the position of R58 in Ste2 and Q55 in Mam2, is predicted to interact with TMD 2.
3045A. Lock et al. / Biochimica et Biophysica Acta 1838 (2014) 3036–305170%when only TMD 5, TMD 6 and TMD 7 are aligned. Given this level of
homology betweenMam2 and Ste2 it was not a surprise to observe that
wild-type Ste2 could be functionally expressed in S. pombewhen stim-
ulated with its natural ligand α-factor (Fig. 4B). Comparison of each
receptor's sensitivity to its respective pheromone suggested that Ste2
functioned equivalently to Mam2 in S. pombe (pEC50: Ste2 — 7.87 ±
0.11; Mam2 — 7.88 ± 0.13). The mutant Ste2 receptors, in which the
G56-XXX-G60 motif was mutated to Leu, rendered S. pombe cells unable
to respond to pheromone (Fig. 4B) and is in broad agreement with previ-
ous reports [12]. In contrast toMam2, each individualmutation complete-
ly abolished the pheromone response indicating mechanistic differences
between the receptors. Again application of the operational model for
receptor depletion to the data yielded the α-factor afﬁnity (log KA =
−6.22 ± 0.60) and the relative efﬁcacy for each construct (Table 1). As
observed for Mam2, the values for all three Ste2 mutants were found to
be signiﬁcantly different from the wildtype Ste2 (p b 0.01).
2.5. Mam2 trafﬁcking disrupted upon mutation of small-XXX-small motifs
Given the previous reports that Ste2 receptors containingmutations
in the small-XXX-small motif are not targeted correctly to the plasma
membrane [12], and due to the similarity in the signaling properties of
mutant Ste2 and Mam2 receptors, the subcellular distribution of all
Mam2 (and Ste2, for comparison) mutants was investigated usingconfocal microscopy. Each mutant was generated as a C-terminal in-
frame fusion to GFP and expressed from the pREP3x vector in the
yeast strain JY1169 (Fig. 4C). To provide a robust measure of the subcel-
lular distribution of the receptormutantswe utilized theQuimP2 plugin
of ImageJ [40] as a quantitative measure of the ﬂuorescence at the pe-
riphery of cells (Table S2). Whereas wild-type Mam2-GFP localized to
the plasmamembrane, themutants appeared to localize to intracellular
structures (Fig. 4C) [20]. Quantiﬁcation of the peripheral membrane lo-
calization indicated that the Mam2S53L, Mam2A57L and Mam2G49L,S53L
and Mam2S53L,A57L mutants all display severely reduced plasma mem-
brane localization (Fig. 4D–Table S2). The extent of the reduction in
plasma membrane expression directly paralleled the reduction in sig-
naling observed for these mutants. A similar trend was observed for
the Ste2 small-XXX-small motifmutantswhere conversion of either gly-
cine residue to leucine reduced plasmamembrane expression between
4 and10-fold (Fig. 4C andD–Table S2),with this reduction in expression
directlymirrored in the reduced signaling characteristics. Correcting the
signaling response (analogous to themethod used inWeston et al. [38])
to account for reduced membrane expression of both Mam2 (Fig. 4F)
and Ste2 (Fig. 4G) revealed that all mutant receptors were functional
although only the Mam2 mutants displayed signiﬁcant (p b 0.01) re-
duction in their potency (pEC50: Mam2-GFP — 7.79 ±0.12; Mam2S53L-
GFP — 7.21 ± 0.10, Mam2S53L-GFP — 6.71 ± 0.08, Mam2A57L-GFP —
6.63 ± 0.06, Mam2G49L,S53L-GFP — 7.00 ± 0.08 and Mam2S53L,A57L-GFP
Fig. 6. Trans-activation enables functional characterization of a heterodimer betweenMam2 and Ste2. Trans-activation requires the co-expression of two receptors; a functional receptor
fused to an inactive Gα-subunit, and an inactive receptor fused to an active Gα-subunit. To demonstrate the functional heterodimerization ofMam2 and STE2A)Mam2-Gpa1[G243A] and
STE2-Gpa1 or B)Mam2-Gpa1 and STE2-Gpa1[G243A]were co-expressed and responsesweremeasured using theβ-galactosidase assay. C) Constructs as shown expressed in the S. pombe
cells lacking bothMam2 and Gpa1 (JY1241). Activities weremeasured using the β-galactosidase assay in response to stimulation with no ligand, 1 μMP-factor or 1 μMα-factor. Means of
triplicate results + SEM are shown.
3046 A. Lock et al. / Biochimica et Biophysica Acta 1838 (2014) 3036–3051— 6.76 ± 0.04). These data would suggest that mutation of the small-
XXX-small motif of Mam2 speciﬁcally affects receptor trafﬁcking and
functionality while for Ste2 it appears to only affect plasma membrane
translocation.
2.6. Cross-talk between Mam2 and Ste2 is mediated via small-XXX-small
interactions
The presence of complementary small-XXX-small motifs in the ﬁrst
TMD of both Mam2 and Ste2, motifs which have been shown to facili-
tate both homo- and hetero-association of membrane-embedded α-
helices [52,53], led us to investigate whether a functional interaction
might occur between these two receptors. We have previously de-
scribed the use of GPCR-Gpa1 fusion constructs to investigateMam2 di-
merization through the principle of GPCR trans-activation [20]. Brieﬂy, a
receptor of choice is fused directly-in frame to an active Gpa1 or a mu-
tant of Gpa1[G234A] that is unable to displace GDP [20]. Then by using
the principle described in Fig. 6A and Bwe are able to express combina-
tions of the Mam2 and Ste2 fusion constructs to determine if these re-
ceptors generate functional heterodimers. Co-expression of Mam2-
Gpa1[G243A] with Ste2-Gpa1 (in cells lacking endogenous Mam2 and
Gpa1) following stimulation with 1 μM P-factor was able to generate a
signaling response (Fig. 6C). Given that Mam2 fused to the inactive
Gpa1 (Mam2-Gpa1[G243A]) fails to elicit a response upon stimulation
with P-factor, we would suggest that transactivation of response occursfrom the ligand-occupiedMam2 to the functional Gpa1 fused onto Ste2.
We have shown previously that Mam2-Gpa1[G243A] is unable to acti-
vate Gpa1 in the absence of the formation of a dimer [20]. Consequently
we suggest that the two related fungal GPCRs can form a functional
dimer pair. The converse situation also applied when Ste2-Gpa1
[G243A] was co-expressed with Mam2-Gpa1 and stimulated with
1 μM α-factor.
We next sought to determine if this heterodimer between Ste2 and
Mam2 displayed any unique pharmacological properties. To achieve
this, we made use of a series of S. pombe Gα-transplant reporter strains
[21]. While these strains are generally used to investigate the Gα-
speciﬁcity of human GPCRs, [7] we have previously used these strains
to investigate the proﬁle of Gα-transplants activated by Mam2 [20]. In
our current study we not only investigated the Gα-speciﬁcity of Mam2
in these Gα-transplant reporter strains (Fig. 7A) but also extended
these studies to include Ste2 (Fig. 7B). Consistentwith our previous anal-
yses, we observed that Mam2, when stimulated with 1 μMP-factor, acti-
vated the Gαq and Gα16 transplants to a similar extent as Gpa1, while the
Gαi3 transplant displayed a reduced but signiﬁcant level of response. In
contrast to our previous study, we did not observe a signiﬁcant response
from the Gαi2 transplant strain, and this may reﬂect a difference in the
extent of receptor expression between the two studies. Here we are
using the pREP4x plasmid to drive Mam2 expression (enabling co-
expressing with Ste2 as described below) and this may produce a
lower level of expression than the pREP3x vector used in our previous
3047A. Lock et al. / Biochimica et Biophysica Acta 1838 (2014) 3036–3051study [21]. To facilitate immunoblotting to conﬁrm the expression of the
Mam2, we expressed the C-terminal fusion of Mam2 tagged with GFP
(Fig. 7A). Membrane extracts generated from the Gαi3 transplant strain
conﬁrmed the expression of Mam2-GFP and also highlighted the exis-
tence of higher order oligomeric states (see Fig. 7A, inset). As we have
described previously [20] a smaller species of about 30 kDa was also ob-
servedwhichwe attributed to being a breakdownproduct ofMam2-GFP.
Using a similar approach, the proﬁle of Gα-transplant reporter
strains activated by Ste2 was investigated in response to 1 μM α-
factor (Fig. 7B). Comparable to Mam2, when Ste2 was stimulated by25
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Mam2-GFPits endogenous ligand (α-factor), the Gαq and Gα16 transplant strains
were activated to an equivalent extent as the endogenous Gpa1 strain.
Unlike Mam2, Ste2 was unable to stimulate the Gαi3 transplant strain
despite showing good expression and the existence of high order oligo-
meric states (when analyzed using a hexahistidine tag under non-
reducing conditions, Fig. 7B, inset). Ste2 has previously been demon-
strated to be N-terminally glycosylated on two sites [54] and hence
the existence of multiple bands for the monomer and dimer states.
The inability of Ste2 to activate a yeast/human Gαi3 transplant in
S. pombe is entirely consistent with that reported when similar chi-
meras have been expressed in S. cerevisiae [55]. Moreover, to ensure
the highest level of expression possible of Ste2 we have used the
pREP3x vector with cells grown in the absence of thiamine.
These results show distinctive G protein activation proﬁles for
Mam2 and Ste2 in response to their native ligands. To determine if
Mam2 and Ste2 could form a functional complex, we co-expressed the
two receptors in the Gα-transplant reporter strains and stimulated
the cells with either 1 μMP-factor or 1 μMα-factor (Fig. 7C). In response
to P-factor stimulation, the activation proﬁle of the co-expressed recep-
tors resembled that of Mam2 expressed alone, but with a reduced over-
all level of signaling, possibly due to Ste2 sequestering some of the Gα
pool. When the same strains were stimulated with α-factor, we ob-
served an activation proﬁle consistent with that observed for Ste2
alone, but with the additional activation of the Gαi3 transplant. This
transplant was not activated when Ste2 was expressed alone, and sug-
gests that Mam2 inﬂuences the Gα speciﬁcity of Ste2 in response to
α-factor. Furthermore, immunoblotting (using non-reducing condi-
tions) of plasma membrane extracts isolated from the Gi3 transplant
strain (Fig. 7C, insets) against His6 revealed the presence of a species
that did not correspond to Ste2-His6 alone. To conﬁrm that this new
band was not simply due to differential sample loading in the two
blots, a loading control was run for each and is shown in Fig. S3. This
new species was approximately 15 kDa larger than the predicted size
for a Ste2-His6 homo-dimer andwas the correct size expected for a het-
erodimer of Ste2-His6 with Mam2-GFP.
Having established the potential for Ste2 and Mam2 to form a func-
tional complex, we sought to determine if the small-XXX-small motifs
present in TMD 1 of both receptors facilitated this interaction. We
have reported that the trafﬁcking and activities of Mam2G49L,S53L and
Ste2 G56L,G60L were severely affected compared to their respective
wild-type receptors (Fig. 4A–B)when expressed individually.We there-
fore wondered if co-expression of a wildtype receptor with a mutant
receptor would overcome the trafﬁcking and activities' defects. To facil-
itate a clear distinction between the mutant and wildtype receptor we
used the ability of Mam2 to dimerize with Ste2 as our functional
readout. Therefore we co-expressed mutant receptors with wildtype
partners and investigated the Gα-speciﬁcity proﬁles (Fig. 8). TheFig. 7. Heterodimer of Mam2 and Ste2 displays altered G protein selectivity compared to
the homodimers. A series of S. pombe reporter strains containing a different Gα-transplant
but all lacking Mam2, was transformed with (A) pREP4x-Mam2, (B) pREP3x-Ste2, and
(C) both pREP4x-Mam2 and pREP3x-Ste2. Cells were grown in the absence of thiamine
to induce full expression from the nmt1 promoter and production of β-galactosidase from
each Gα-transplant strain was assayed using ONPG as a substrate. (A) Cells expressing
Mam2 were exposed to no ligand (blue columns), 1 μM P-factor (red columns) or 1 μM
α-factor (green columns) for 16 h and β-galactosidase production assayed. Mam2-GFP
expressionwas conﬁrmed by immunoblotting of plasmamembrane extracts (10mg) pre-
pared from the Gαi3 transplant strain. Samples were separated by non-reducing SDS-
PAGE, and western blots were probed using a rabbit GFP monoclonal antibody. Indicated
are sizes for monomeric Mam2-GFP and the putative dimer (100 kDa). A smaller band of
30 kDa was observed and has been previously suggested to be a breakdown product of
Mam2-GFP. (B) Cells expressing Ste2were assayed as in A. Ste2-His6 expressionwas con-
ﬁrmed by immunoblotting of plasma membrane extracts (10 mg) prepared from the Gi3
transplant strain using a rabbit polyclonal anti-6-His antibody. Indicated are sizes for mo-
nomeric Ste2-His6 and the putative dimer. (C) Cells co-expressing Mam2 and Ste2 were
assayed as in A. Membrane extracts were generated from the Gαi3 transplant strains and
probed using a rabbit polyclonal anti-6-His antibody only. Indicated are sizes for mono-
meric Ste2-His6 and theMam2-GFP/Ste2-His6 dimer. Results are means ± S.E.M. for trip-
licate measurements from three independent isolates.
Fig. 8. Effect of small-XXX-small mutants on Mam2-Ste2 hetero-association. The strains
JY1160 (expressing the G
i3
transplant), JY1165 (G
q
), JY1167 (G
16
) and JY1169 (Gpa1)
were transformed with (A) pREP4x-Mam2 & pREP3x-Ste2(G56L,G60L), (B) pREP4x-
Mam2(G49L,S53L) & pREP3x-Ste2 and (C) pREP4x-Mam2(G49L,S53L) & pREP3x-Ste2(G56L,G60L).
Cellswere grown in the absence of thiamine to induce full expression from thenmt1promot-
er and production of β-galactosidase from each Gα-transplant strain in response to stimula-
tion with no ligand, 1 μM P-factor and 1 μM α-factor was assayed using ONPG as substrate.
Results aremeans± S.E.M. for triplicatemeasurements from three independent isolates. In-
sets from panels (A–C) are molecular models obtained from searches of the corresponding
mutant hetero-dimer. The predominant structure observed in all three cases is a dimer sta-
bilized by a pair of polar residues (small-XXX-small motifs or their mutants, shown in space
ﬁlling representation, are excluded from the interface).
3048 A. Lock et al. / Biochimica et Biophysica Acta 1838 (2014) 3036–3051activation proﬁle upon addition of 1 μM P-factor for Gα-transplant
strains expressing wildtype Mam2 and Ste2G56L,G60L was reminiscent
of that for Mam2 expressed alone (Fig. 8A). In contrast, 1 μM α-factor
induced a minimal response in Gα-transplant strains. This suggests
that Mam2–Ste2 interactions were disrupted, and the responses ob-
served were predominantly from Mam2. The reverse conﬁguration of
receptors, Mam2G49L,S53L and wildtype Ste2 (Fig. 8B), gave a similar ac-
tivation proﬁle to Ste2 alone in response toα-factor stimulation, except
that the maximal level of signaling was reduced when co-expressed
with Mam2G49L,S53L. Co-expression of Mam2G49L,S53L and Ste2G56L,G60L
(Fig. 8C) yielded a limited response to P-factor in the Gαi3, Gαq and
Gα16 transplant strains, and Gpa1 in response to either pheromone,
but no signaling through Gαi3 was observedwhen the cells were stimu-
lated with α-factor suggesting abolishment of any interaction between
the two receptors. Together, these data suggest a role for the conserved
TMD 1 small-XXX-small motifs in hetero-association of Mam2 and Ste2.
Moreover, co-expression of wildtype receptorswithmutants displaying
trafﬁcking and functional defects could not restore functionality to the
mutants.
Computational models (created using CHI as before) of Ste2-Mam2
TMD 1 hetero-dimers support these results. Structures containing the
Mam2 S-XXX-A and the Ste2 G-XXX-G motifs packed at the hetero-
dimer interface were reproducibly found (see Fig. 3G for a representa-
tive structure), illustratinghow these twoGPCRs could interact via com-
plementary small-XXX-small motifs located in TMD 1. Two additional
types of interactions were also found at the heterodimer interface:
(i) theMam2 S-XXX-Amotif close-packing against an alternative helical
face of Ste2 TMD1 (Fig. 3H); (ii) Q55 inMam2 forming an interhelical H-
bond with R58 in Ste2 (Fig. 3I). These interactions were not investigated
further (e.g. via mutagenesis) here. To simulate the impact of introduc-
ing Leu residues into the heterodimer interface, the mutants described
in Fig. 8 were translated into molecular models and CHI searches were
again used to probe low energy conﬁgurations. In all three cases, muta-
tion of small-XXX-small motifs at the proposed heterodimer interface
overwhelmingly yielded heterodimers that favored interhelical H-
bond formation between Q55 from Mam2 and R58 from Ste2. Typical
structures for the appropriate TMD pair are shown in Fig. 8D–F, and re-
semble an arrangement also observed forwild-type (Fig. 3I). Thiswould
suggest that, in the absence of complementary small-XXX-small motifs,
the most favorable interaction for the isolated TM domains is that be-
tween Q55 and R58. Given the overwhelming experimental support for
the role of small-XXX-small motifs in this work, the fact that interaction
of Q55/R58 would require a ~180° rotation of the TMD 1 helices from
their small-XXX-small-containing faces, and the previous report that in
Ste2 R58 forms part of the ligand binding site [49], it seems unlikely
that thehetero-interaction could be accommodated via both types of in-
teractions. However, more work is required to conﬁrm this.
3. Discussion
Recently, the accumulation of pharmacological andbiochemical data
has signiﬁcantly challenged the notion that GPCRs act as monomers
[56–60] transducing signals to a heterotrimeric G protein, although
this is not without controversy. Some of the early evidence for GPCR di-
merization came from unexplained cooperativity observed in ligand
binding assays and abnormally large receptor complexes observed
using gel ﬁltration [61–63]. Oligomerization of GPCRs was originally
centered upon receptor self-association (homo-dimerization), with
studies of the fungal GPCRs Ste2 [10,12] and Mam2 [21] playing signif-
icant roles. There is now an ever-increasing list of receptors that have
been suggested to associate with other GPCRs (hetero-dimerization),
and many of these examples have been summarized in an excellent
recent review [64]. However, certain concerns remain in the ﬁeld that
these interactions are due to experimental artifacts. For example,
frequently GPCRs are overexpressed in a given assay system or contain
large ﬂuorescent moieties that themselves promote oligomerization.
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dimerization are FRET and BRET techniques, however these methods
often require removal of the C-terminal intracellular tail of the receptor
to enable ﬂuorophores to come into close proximity and create a signal
[10,12]. Where such studies are coupled to functional data, the case for
hetero-dimerization is more compelling. GPCR hetero-dimerization
may also be responsible for efﬁcient trafﬁcking of receptors to the plas-
ma membrane, with a clear example being the GABAB receptor. To
enable cell surface expression of a functional GABAB receptor, two
distinct but related GPCRs (GABABR1 and GABABR2) must be co-
expressed in cells [65]. More recent work has shown that classical Fam-
ily A receptors such as the β-adrenergic receptors [66–68] can also un-
dergo hetero-dimerization. However, despite multiple examples, the
mechanisms used by receptors to promote oligomerization are not
clearly understood.
Here we present an array of biochemical, computational and cellular
data demonstrating for theﬁrst time that a highly conserved small-XXX-
small motif found in TMD 1 of the fungal GPCRMam2 promotes TMD 1
self-association. We provide molecular models for these interactions
that are chemically plausible and in very good agreement with experi-
ment. Given the potential importance of dimerization on efﬁcient
GPCR plasma membrane trafﬁcking, we investigated the effects of per-
turbations of the small-XXX-small motif in Mam2 in vivo. Consistent
with our predictions, and with results obtained in parallel for the ho-
mologous GPCR Ste2, disruption of the close packing of the TMD 1
motif reduced the ability of both receptors to respond to their native
pheromones, and resulted in impaired plasma membrane expression.
3.1. GPCR dimerization interfaces
Oligomerization of some GPCRs appears to bemediated by extracel-
lular regions, for instance the metabotropic glutamate receptors dimer-
ize via disulphide bond formation [69] and dimerization of the CXCR4
receptor appears to be driven by the hydrophobic effect involving the
extracellular regions of TMDs 5 and 6 [70]. Oligomerization driven by
interactions formed in the TM bundle is also poorly characterized in
the literature, but small-XXX-small motifs have been implicated. For
instance, a G-XXX-G motif drives the oligomerization of the beta2-
adrenergic receptor [71] and, as discussed in this work, contributes to
the oligomerization of the S. cerevisiae Ste2 pheromone GPCR [10,12].
Interestingly the beta2-adrenergic receptor appears to be an isolated
case since the small-XXX-small in TM6 is not conserved in Family A
GPCRs [36].
Although a G-XXX-G motif in TMD 1 of Ste2 has been highlighted in
homo-oligomer formation, we present data here which indicate, sur-
prisingly, that Ste2 TMD 1 only weakly self-associates in isolation in a
natural membrane (albeit a bacterial membrane) and is unlikely to
single-handedly direct oligomerization outside the context of the full-
length receptor. This would suggest one of two things, either (a) that
TMD 1 does not participate in intermolecular interactions but instead
stabilizes intramolecular contacts that lead to the correct folding of
the protein, or (b) that TMD 1 works in concert with other regions of
the protein to facilitate intermolecular interactions. In a Ste2 homo-
dimer, for example, more than one TMD could be in contact at one
time depending on the arrangement of the proteins in the dimer. In-
deed, the N-terminus, TMD 2, TMD 4, and TMD 7 of Ste2 have also
been implicated in direct protein-protein interactions [9–11], while
the opsin dimer (Fig. 5) is held together by additional contacts within
TMD 2 and helix 8.
Similar to Ste2, the orthologous S. pombe pheromone receptor
Mam2 also contains amotif of small residues (S-XXX-A) at the same po-
sition in TMD 1 (indeed this motif is conserved through several mem-
bers of Class D GPCRs, see Fig. 2) and also forms homo-oligomeric
complexes [20]. In contrast to Ste2, we show thatMam2 TMD1 strongly
self-associates in a naturalmembrane in a sequence dependentmanner
via the S-XXX-A motif suggesting that Mam2 TMD 1 may be capable ofdriving self-association of the receptor. Despite these differences in
the mechanism of self-association of the two GPCRs, mutation of the
complementary small-XXX-small motifs found in TMD 1 had a similar
impact on the function and localization of both proteins. Substitution
of the small Ala, Ser or Gly residues with Leu severely impaired the
pheromone response of both proteins and greatly reduced the plasma
membrane expression levels (receptors were instead found in intracel-
lular compartments) suggesting inefﬁcient folding of the GPCRs.3.2. Functional hetero-dimerization of fungal GPCRs
The fungal GPCRs constitute the fourth family of GPCRs (class D —
fungal mating pheromone receptors) and display little signiﬁcant inter-
species sequence conservation. For example, the two-pheromone
receptors from S. cerevisiae (Ste2 and Ste3) only share 15% homology,
consequently the receptors have been given their own unique 7 TM clas-
siﬁcation. Between species however, the receptors aremore homologous
(Mam2 and Ste2 share 70% homology over the TMDs 5, 6 and 7).While it
is highly unlikely that intra-species fungal GPCR dimerization would
functionally occur, there have been reports that during cell fusion Ste2
and Ste3 may form a dimeric complex that mediates cell wall digestion
and membrane juxtaposition before fusion [72]. Despite this report, no
information is available relating to the potential dimeric interface be-
tween Ste2 and Ste3. Further, based upon our alignments, Ste3would ap-
pear not to have a conserved small-XXX-small motif and indeed may
resemble more the traditional small-XX-small motif of Family A GPCRs
(Reynolds et al., unpublished work). The only other descriptions to date
of fungal GPCR heterodimerization relates to the use of artiﬁcially
expressed constitutive and dominant negative versions of receptors [20,
73,74]. Our ability to functionally express the S. cerevisiae pheromone re-
ceptor Ste2 in S. pombe has enabled us to demonstrate here, for the ﬁrst
time, the propensity of highly related yet species-distinct GPCRs Ste2
andMam2 to formhetero-dimers. Their structural and functional similar-
ity, and the complementary positioning of a well-studied helix–helix
interactionmotif, suggested the possibility of the formation of a function-
al heterodimer. This was conﬁrmed through the use of previously
described S. pombe Gα-transplant strains [21] and immunoblotting. Per-
turbation of the small-XXX-small motif in either receptor abolished func-
tional heterodimer formation.3.3. Implications beyond yeast
The data presented in this study highlight the wide array of in vitro
and in vivo techniques available for the investigation of GPCR oligomer-
ization, aswell as thepotential of small-XXX-smallmotifs to promote in-
teractions and facilitate correct membrane trafﬁcking in this context.
While biologically our identiﬁcation of a functional heterodimeric com-
plex between two GPCRs from different yeast species (Ste2 andMam2)
is unlikely to occur in nature, it does highlight the potential for related
GPCRswith homology between their TMDs to associate. Physiologically,
an interaction between Ste2 and Mam2 will not occur, however given
their structural similarities they represent an excellent model to study
hetero-dimerization of related-GPCRswithout the complication of com-
peting ligands. Given that a number of mammalian GPCRs contain the
small-XXX-small motif in their TMDs [10], some of which have been
demonstrated to promote oligomerization (e.g. the beta2-adrenergic
receptor [71]) even though the motif is not conserved in the class as a
whole, it will be of great interest to determine if any of these facilitate
functional homo-dimer and hetero-dimer couplings.Acknowledgements
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Alignment of full-length Ste2 and Mam2, western blots to measure
expression levels of all TOXCAT constructs used in this study, and load-
ing controls are provided, so are tables listing all Schizosaccharomyces
pombe strains used in this study, peripheral membrane intensities and
percentagemean ﬂuorescence values for Mam2 and Ste2mutants. Sup-
plementary data to this article can be found online at http://dx.doi.org/
10.1016/j.bbamem.2014.08.019.References
[1] S.G. Rasmussen, B.T. DeVree, Y. Zou, A.C. Kruse, K.Y. Chung, T.S. Kobilka, F.S. Thian,
P.S. Chae, E. Pardon, D. Calinski, J.M. Mathiesen, S.T. Shah, J.A. Lyons, M. Caffrey, S.
H. Gellman, J. Steyaert, G. Skiniotis, W. Weis, R.K. Sunahara, B.K. Kobilka, Crystal
structure of the β2 adrenergic receptor–Gs protein complex, Nature 477 (2011)
549–555.
[2] F. Xu, H. Wu, V. Katritch, G.W. Han, K.A. Jacobson, Z.G. Gao, V. Cherezov, R.C. Stevens,
Structure of an agonist-bound human A2A adenosine receptor, Science 332 (2011)
322–327.
[3] S. Terrillon, M. Bouvier, Roles of G-protein-coupled receptor dimerization, EMBO
Rep. 5 (2004) 30–34.
[4] R.J. Ward, T.R. Xu, G. Milligan, GPCR oligomerization and receptor trafﬁcking,
Methods Enzymol. 521 (2013) 69–90.
[5] F.M. Décaillot, M.A. Kazmi, Y. Lin, S. Ray-Saha, T.P. Sakmar, P. Sachdev, CXCR7/CXCR4
heterodimer constitutively recruits beta-arrestin to enhance cell migration, J. Biol.
Chem. 286 (2011) 32188–32197.
[6] P. Chandrasekera, T. Wan, E. Gizewski, J. Auchampach, R. Lasley, Adenosine
A(1) receptors heterodimerize with beta(1)- and beta(2)-adrenergic receptors cre-
ating novel receptor complexes with altered G protein coupling and signaling, Cell.
Signal. 25 (2013) 736–742.
[7] G. Ladds, J. Davey, Analysis of human GPCRs in ﬁssion yeast, Curr. Opin. Drug Discov.
Dev. 7 (2004) 683–691.
[8] A.U. Gehret, A. Bajaj, F. Naider, M.E. Dumont, Oligomerization of the yeast alpha-
factor receptor: implications for dominant negative effects of mutant receptors, J.
Biol. Chem. 281 (2006) 20698–20714.
[9] H. Kim, B.K. Lee, F. Naider, J.M. Becker, Identiﬁcation of speciﬁc transmembrane res-
idues and ligand-induced interface changes involved in homo-dimer formation of a
yeast G protein-coupled receptor, Biochemistry 48 (2009) 10976–10987.
[10] M.C. Overton, K.J. Blumer, The extracellular N-terminal domain and transmembrane
domains 1 and 2 mediate oligomerization of a yeast G protein-coupled receptor, J.
Biol. Chem. 277 (2002) 41463–41472.
[11] H.X.Wang, J.B. Konopka, Identiﬁcation of amino acids at two dimer interface regions
of the alpha-factor receptor (Ste2), Biochemistry 48 (2009) 7132–7139.
[12] M.C. Overton, S.L. Chinault, K.J. Blumer, Oligomerization, biogenesis, and signaling is
promoted by a Glycophorin A-like dimerization motif in transmembrane domain 1
of a yeast G protein-coupled receptor, J. Biol. Chem. 278 (2003) 49369–49377.
[13] B. Brosig, D. Langosch, The dimerization motif of the glycophorin A transmembrane
segment in membranes: importance of glycine residues, Prot. Sci. 7 (1998)
1052–1056.
[14] Z.A. Jenei, K. Borthwick, V.A. Zammit, A.M. Dixon, Self-association of transmembrane
domain 2 (TM2), but not TM1, in carnitine palmitoyltransferase 1A: role of
GXXXG(A) motifs, J. Biol. Chem. 284 (2009) 6988–6997.
[15] A. Rath, C.M. Deber, Surface recognition elements of membrane protein oligomeri-
zation, Proteins 70 (2008) 786–793.
[16] D. Gerber, N. Sal-Man, Y. Shai, Two motifs within a transmembrane domain, one for
homodimerization and the other for heterodimerization, J. Biol. Chem. 279 (2004)
21177–21182.
[17] F. Cunningham, B. Poulsen, W. Ip, C. Deber, Beta-branched residues adjacent to GG4
motifs promote the efﬁcient association of glycophorin A transmembrane helices,
Biopolymers 96 (2011) 340–347.
[18] A. Doura, F. Kobus, L. Dubrovsky, E. Hibbard, K. Fleming, Sequence context modu-
lates the stability of a GxxxG-mediated transmembrane helix–helix dimer, J. Mol.
Biol. 341 (2004) 991–998.
[19] K. Kitamura, C. Shimoda, The Schizosaccharomyces-pombe Mam2 gene encodes a
putative pheromone receptor which has a signiﬁcant homology with the
saccharomyces-cerevisiae Ste2 protein, EMBO J. 10 (1991) 3743–3751.
[20] G. Ladds, K. Davis, A. Das, J. Davey, A constitutively active GPCR retains its G protein
speciﬁcity and the ability to form dimers, Mol. Microbiol. 55 (2005) 482–497.
[21] G. Ladds, K. Davis, E.W. Hillhouse, J. Davey, Modiﬁed yeast cells to investigate the
coupling of G protein-coupled receptors to speciﬁc G proteins, Mol. Microbiol. 47
(2003) 781–792.
[22] W. Croft, C. Hill, E. McCann, M. Bond, M. Esparza-Franco, J. Bennett, D. Rand, J. Davey,
G.A. Ladds, A physiologically required G protein-coupled receptor (GPCR)-regulator
of G protein signaling (RGS) interaction that compartmentalizes RGS activity, J. Biol.
Chem. 288 (2013) 27327–27342.
[23] B. Smith, C. Hill, E. Godfrey, D. Rand, H. van den Berg, S. Thornton, M. Hodgkin, J.
Davey, G.A. Ladds, Dual positive and negative regulation of GPCR signaling by GTP
hydrolysis,, Cell. Signal. 21 (2009) 1151–1160.
[24] W.P. Russ, D.M. Engelman, TOXCAT: a measure of transmembrane helix association
in a biological membrane, Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 863–868.[25] M.D. Abramoff, P.J. Magalhaes, S.J. Ram, Image processing with ImageJ, Biophoton.
Int. 11 (2004) 36–42.
[26] J. Davey, R. Egel.,, O. Neilsen, Pheromone procedures in ﬁssion yeast, Methods Mol.
Genet. 6 (1995) 247–263.
[27] G. Ladds, E.M. Rasmussen, T. Young, O. Nielsen, J., D., The sxa2-dependent inactiva-
tion of the P-factor matin pheromone in the ﬁssion yeast, Mol. Microbiol. 20 (1996)
35–42.
[28] K. Maundrell, Thiamine-repressible expression vectors pREP and pRIP for ﬁssion
yeast, Gene 123 (1993) 127–130.
[29] M. Didmon, K. Davis, P. Watson, G. Ladds, P. Broad, J. Davey, Identifying regulators of
pheromone signalling in the ﬁssion yeast Schizosaccharomyces pombe, Curr. Genet.
41 (2002) 241–253.
[30] P.D. Adams, D.M. Engelman, A.T. Brünger, Improved prediction for the structure of
the dimeric transmembrane domain of glycophorin A obtained through global
searching, Proteins 26 (1996) 257–261.
[31] A.P. Brünger AT, G.M. Clore, W.L. DeLano, P. Gros, R.W. Grosse-Kunstleve, J.S. Jiang, J.
Kuszewski, M. Nilges, N.S. Pannu, R.J. Read, L.M. Rice, T. Simonson, G.L. Warren,
Crystallography & NMR system: a new software suite for macromolecular structure
determination, Acta Crystallogr. D Biol. Crystallogr. 54 (1998) 905–921.
[32] E. Krissinel, K. Henrick, Inference of macromolecular assemblies from crystalline
state, J. Mol. Biol. 372 (2007) 774–797.
[33] L.M. Simpson, B. Taddese, I.D. Wall, C.A. Reynolds, Bioinformatics and molecular
modelling approaches to GPCR oligomerization, Curr. Opin. Pharmacol. 10 (2010)
30–37.
[34] A. Krogh, B. Larsson, G. von Heijne, E.L. Sonnhammer, Predicting transmembrane
protein topology with a hidden Markov model: application to complete genomes,
J. Mol. Biol. 305 (2001) 567–580.
[35] B. Taddese, G.J. Upton, G.R. Bailey, S.R. Jordan, N.Y. Abdulla, P.J. Reeves, C.A.
Reynolds, Do plants contain G protein-coupled receptors? Plant Physiol. 164
(2014) 287–307.
[36] S. Vohra, B. Taddese, A.C. Conner, D.R. Poyner, D.L. Hay, J. Barwell, P.J. Reeves, G.J.
Upton, C.A. Reynolds, Similarity between class A and class B G-protein-coupled re-
ceptors exempliﬁed through calcitonin gene-related peptide receptor modelling
and mutagenesis studies, J R. Soc Interface 10 (2013) 20120846.
[37] J.H. Park, P. Scheerer, K.P. Hofmann, H.W. Choe, O.P. Ernst, Crystal structure of the
ligand-free G-protein-coupled receptor opsin, Nature 454 (2008) 183–187.
[38] C. Weston, M. Bond, C. Croft, J. Davey, G. Ladds, The coordination of cell growth
during ﬁssion yeast mating requires Ras1-GTP hydrolysis, PLoS ONE 8 (10) (2013)
e77487.
[39] M. Bond, W. Croft, R. Tyson, T. Bretschneider, J. Davey, G. Ladds, Quantitative analy-
sis of human ras localisation and function in the ﬁssion yeast Schizosaccharomyces
pombe, Yeast 30 (2013) 145–156.
[40] L. Bosgraaf, P. van Haastert, T. Bretschneider, Analysis of cell movement by simulta-
neous quantiﬁcation of local membrane displacement and ﬂuorescent intensities
using Quimp2, Cell Motil. Cytoskeleton 66 (2009) 156–165.
[41] D. Dormann, T. Libotte, C. Weijer, T. Bretschneider, Simultaneous quantiﬁcation of
cell motility and protein-membrane association using active contours, Cell Motil.
Cytoskeleton 52 (2002) 221–230.
[42] J.W. Black, P. Leff, Operational models of pharmacological agonism, Proc. R. Soc. B
Biol. Sci. 220 (1983) 141–162.
[43] M.A. Larkin, G. Blackshields, N.P. Brown, R. Chenna, P.A. McGettigan, H.
McWilliam, F. Valentin, I.M. Wallace, A. Wilm, R. Lopez, J.D. Thompson, T.J.
Gibson, D.G. Higgins, Clustal W and Clustal X version 2.0, Bioinformatics 23
(2007) 2947–2948.
[44] J.D. Thompson, T.J. Gibson, F. Plewniak, F. Jeanmougin, D.G. Higgins, The CLUSTAL_X
windows interface: ﬂexible strategies for multiple sequence alignment aided by
quality analysis tools, Nucleic Acids Res. 25 (1997) 4876–4882.
[45] H. Wu, C.Wang, K.J. Gregory, G.W. Han, H.P. Cho, Y. Xia, C.M. Niswender, V. Katritch,
J. Meiler, V. Cherezov, Structure of a class C GPCRmetabotropic glutamate receptor 1
bound to an allosteric modulator, Science 344 (2014) 58–64.
[46] D. Langosch, B. Brosig, H. Kolmar, H.J. Fritz, Dimerisation of the glycophorin A trans-
membrane segment in membranes probed with the ToxR transcription activator, J.
Mol. Biol. 263 (1996) 525–530.
[47] R.M. Johnson, A. Rath, C.M. Deber, The position of the Gly-xxx-Gly motif in trans-
membrane segments modulates dimer afﬁnity, Biochem. Cell Biol. 84 (2006)
1006–1012.
[48] R. Li, R. Gorelik, V. Nanda, P.B. Law, J.D. Lear,W.F. DeGrado, J.S. Bennett, Dimerization
of the transmembrane domain of Integrin alphaIIb subunit in cell membranes, J.
Biol. Chem. 279 (2004) 26666–26673.
[49] C. Son, H. Sargsyan, F. Naider, J. Becker, Identiﬁcation of ligand binding regions of the
Saccharomyces cerevisiae alpha-factor pheromone receptor by photoafﬁnity cross-
linking, Biochemistry 43 (2004) 13193–13203.
[50] A. Goddard, G. Ladds, R. Forfar, J. Davey, Identiﬁcation of Gnr1p, a negative regulator
of Got signalling in Schizosaccharomyces pombe, and its complementation by human
G beta subunits, Fungal Genet. Biol. 43 (2006) 840–851.
[51] D.J. Lipman, W.R. Pearson, Rapid and sensitive protein similarity searches, Science
227 (1985) 1435–1441.
[52] G. King, A.M. Dixon, Evidence for role of transmembrane helix–helix interactions in
the assembly of the class II major histocompatibility complex, Mol. BioSyst. 6 (2010)
1650–1661.
[53] Z.A. Jenei, G.Z. Warren, M. Hasan, V.A. Zammit, A.M. Dixon, Packing of transmem-
brane domain 2 of carnitine palmitoyltransferase-1A affects oligomerization and
malonyl-CoA sensitivity of the mitochondrial outer membrane protein, FASEB J. 25
(2011) 4522–4530.
[54] P. Mentesana, J. Konopka, Mutational analysis of the role of N-glycosylation in
alpha-factor receptor function, Biochemistry 40 (2001) 9685–9694.
3051A. Lock et al. / Biochimica et Biophysica Acta 1838 (2014) 3036–3051[55] A. Brown, S. Dyos, M. Whiteway, J. White, M. Watson, M. Marzioch, J. Clare, D.
Cousens, C. Paddon, C. Plumpton, M. Romanos, S. Dowell, Functional coupling of
mammalian receptors to the yeast mating pathway using novel yeast/mammalian
G protein alpha-subunit chimeras, Yeast 16 (2000) 11–22.
[56] S.R. George, B.F. O'Dowd,, S.P. Lee, G-protein-coupled receptor oligomerization and
its potential for drug discovery, Nat. Rev. Drug Discov. (2002) 808–820.
[57] M.J. Lohse, Dimerization in GPCR mobility and signaling, Curr. Opin. Pharmacol. 10
(2010) 53–58.
[58] G. Milligan, G protein-coupled receptor dimerization: function and ligand pharma-
cology, Mol. Pharmacol. 66 (2004) 1–7.
[59] S.C. Prinster, C., H., R.A. Hall, Heterodimerization of G protein-coupled receptors:
speciﬁcity and functional signiﬁcance, Pharmacol. Rev. 57 (2005) 289–298.
[60] S. Terrillon, T. Durroux, B. Mouillac, A. Breit, M.A. Ayoub, M. Taulan, R. Jockers, C.
Barberis, M. Bouvier, Oxytocin and vasopressin V1a and V2 receptors form constitutive
homo- and heterodimers during biosynthesis, Mol. Endocrinol. 17 (2003) 677–691.
[61] S. Angers, A. Salahpour, M. Bouvier, Dimerization: an emerging concept for G
protein-coupled receptor ontogeny and function, Annu. Rev. Pharmacol. Toxicol.
42 (2002) 409–435.
[62] L.F. Agnati, K. Fuxe, M. Zoli, C. Rondanini, S.O. Ogren, New vistas on synaptic plastic-
ity: the receptor mosaic hypothesis of the engram, Med. Biol. 60 (1982) 183–190.
[63] S.C. Prinster, C. Hague, R.A. Hall, Heterodimerization of G protein-coupled receptors:
speciﬁcity and functional signiﬁcance, Pharmacol. Rev. 57 (2005) 289–298.
[64] G. Milligan, The prevalence, maintenance, and relevance of G protein-coupled re-
ceptor oligomerization, Mol. Pharmacol. 84 (2013) 158–169.
[65] F.H. Marshall, K.A. Jones, K. Kaupmann, B. Bettler, GABAB receptors — the ﬁrst 7TM
heterodimers, Trends Pharmacol. Sci. 20 (1999) 396–399.
[66] C. Lavoie, J.F. Mercier, A. Salahpour, D. Umapathy, A. Breit, L.R. Villeneuve, W.Z. Zhu,
R.P. Xiao, E.G. Lakatta, M. Bouvier, T.E. Hebert, Beta 1/beta 2-adrenergic receptorheterodimerization regulates beta 2-adrenergic receptor internalization and ERK
signaling efﬁcacy, J. Biol. Chem. 277 (2002) 35402–35410.
[67] J.F. Mercier, A. Salahpour, S. Angers, A. Breit, M. Bouvier, Quantitative assessment of
beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by biolumi-
nescence resonance energy transfer, J. Biol. Chem. 277 (2002) 44925–44931.
[68] C. Lavoie, T.E. Hebert, Pharmacological characterization of putative beta1–beta2-
adrenergic receptor heterodimers, Can. J. Physiol. Pharmacol. 81 (2003) 186–195.
[69] C. Romano, W.L. Yang, K.L. O'Malley, Metabotropic glutamate receptor 5 is a
disulﬁde-linked dimer, J. Biol. Chem. 271 (1996) 28612–28616.
[70] B. Wu, E.Y. Chien, C.D. Mol, G. Fenalti, W. Liu, V. Katritch, R. Abagyan, A. Brooun, P.
Wells, F.C. Bi, D.J. Hamel, P. Kuhn, T.M. Handel, V. Cherezov, R.C. Stevens, Structures
of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists,
Science 330 (2010) 1066–1071.
[71] T.E. Hebert, S. Moffett, J.P. Morello, T.P. Loisel, D.G. Bichet, C. Barret, M. Bouvier, A
peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits
both receptor dimerization and activation, J. Biol. Chem. 271 (1996) 16384–16392.
[72] C. Shi, S. Kaminskyj, S. Caldwell, M.C. Loewen, A role for a complex between activat-
ed G protein-coupled receptors in yeast cellular mating, Proc. Natl. Acad. Sci. U. S. A.
104 (2007) 5395–5400.
[73] M. Dosil, J.B. Konopka, Strategies for isolating constitutively active and dominant-
negative pheromone receptor mutants in yeast, Methods Enzymol. 485 (2010)
329–348.
[74] C. Xue, Y.P. Hsueh, J. Heitman, Magniﬁcent seven: roles of G protein-coupled recep-
tors in extracellular sensing in fungi, FEMS Microbiol. Rev. 32 (2008) 1010–1032.
[75] P.C. Ng, J.G. Henikoff, S. Henikoff, PHAT: a transmembrane-speciﬁc substitution ma-
trix predicted hydrophobic and transmembrane, Bioinformatics 16 (2000) 760–766.
[76] M. Clamp, J. Cuff, S.M. Searle, G.J. Barton, The Jalview Java alignment editor, Bioinfor-
matics 20 (2004) 426–427.
